DigitalOwl, a company that uses natural language processing to help analyze and summarize EHRs, announced it is collaborating with ExamOne, a Quest Diagnostics company, to improve efficiency of record retrieval and analysis through DigitalOwl’s…
Continue Reading
The following is a guest article by Jeff Lusby, Executive Director and General Manager, Healthcare IT at Quest Diagnostics, with contributions from Keith Johnson, Senior Corporate Counsel at Quest Diagnostics
In healthcare, the focus is…
Funding will Support Expanded Commercialization Efforts for PreciseBreast Risk Assessment
PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today announced that it has raised $20.7 million in…
The following is a guest article by Bernard Steinbacher, CPC, MS, MD, and Senior Medical Director at Lyric
The landscape of laboratory payments in healthcare is complex and evolving, presenting both significant challenges and opportunities…
What You Should Know:
– PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital…
Continue Reading
What You Should Know:
– Quest Diagnostics today announced it will acquire key assets of PathAI Diagnostics, including its state-of-the-art digital pathology laboratory in Memphis, Tennessee.
– As part of the acquisition, this facility will become…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
What You Should Know:
– Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.
– This…
Continue Reading
Behemoth lab test company Quest Diagnostics is partnering with Google’s Fitbit to study how wearable technologies can improve metabolic health. The pilot study, dubbed Wearables for Metabolic Health (WEAR-ME), will combine Fitbit’s behavioral and biometric…
Continue Reading
